CNTA - Company ID 0001847903
The table below shows Centessa Pharmaceuticals plc's balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $61.30M | $383.22M | $128.03M | $393.64M | $595.08M |
| Short-term investments | $233.28M | $98.96M | $128.52M | - | - |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $367.88M | $536.41M | $315.09M | $437.75M | $628.77M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $807.00K | $744.00K | $1.04M | $1.17M | $162.00K |
| Goodwill | - | - | - | - | - |
| Total assets | $687.50M | $576.80M | $360.25M | $444.31M | $629.63M |
| Accounts payable | $7.58M | $7.14M | $11.81M | $13.84M | $8.06M |
| Total current liabilities | $42.94M | $58.00M | $39.38M | $38.34M | $24.64M |
| Long-term debt | $110.09M | $108.94M | $75.70M | $69.80M | $75.70M |
| Total liabilities | $160.63M | $175.25M | $124.00M | $108.14M | $138.08M |
| Retained earnings | -$1.19B | -$988.70M | -$752.95M | -$601.86M | -$385.65M |
| Total equity | $526.86M | $401.55M | $236.24M | $336.17M | $491.55M |